Persönliches Profil
Wissenschaftliche Laufbahn
Professor Angela Casini completed her PhD in Chemistry at the University of Florence (Italy) in 2004, and, afterwards, moved to EPFL (Switzerland) as principal investigator funded by the Swiss National Science Foundation. Between 2011-2015 she was assistant professor at the University of Groningen (The Netherlands), holding a Rosalind Franklin Fellowship. Between 2015-2019, she was also Chair and Director of Postgraduate Taught Masters at Cardiff University (UK), before taking up her current position at TUM in 2019. At TUM, Angela is also Liesel Beckmann Distinguished Professor and Core member of the Munich Institute of Data Science (MDSI), as well as Associated Researcher of the Catalysis Research Center (CRC). Since December 2021, Angela is ad interim manager (kommissarischen Leiterin) of the Chair of Pharmaceutical Radiochemistry at TUM.
Bildung/Akademische Qualifikationen
Promovend, “Carbonic Anhydrase Inhibitors with possible pharmacological applications, University of Florence
Datum der Bewilligung: 23 Nov. 2004
Mastergrad, DNA as a target for Ruthenium(III) complexes acting as anticancer agents, University of Florence
Datum der Bewilligung: 19 Dez. 1998
Schlagwörter
- QD Chemistry
Kompetenzen im Bereich UN SDGs
2015 einigten sich UN-Mitgliedstaaten auf 17 globale Ziele für nachhaltige Entwicklung (Sustainable Development Goals, SDGs) zur Beendigung der Armut, zum Schutz des Planeten und zur Förderung des allgemeinen Wohlstands. Die Arbeit dieser Person leistet einen Beitrag zu folgendem(n) SDG(s):
-
SDG 3 – Gute Gesundheit und Wohlergehen
Fingerprint
- 1 Ähnliche Profile
Kooperationen und Spitzenforschungsbereiche der letzten fünf Jahre
-
UbiQancer: Functionalizing the Ubiquitin System against Cancer
Casini, A. (Leitende(r) Forscher/-in)
1/10/24 → 30/06/28
Projekt: Forschung
-
Organogold compounds as “smart” residue specific chemical modifiers: towards new generation Gold-PROTACs (B03)
Casini, A. (Leitende(r) Forscher/-in)
1/01/24 → …
Projekt: Forschung
-
SMARTdrugs: Supramolecular Agents as Radiotheranostic Drugs
Casini, A. (Leitende(r) Forscher/-in)
1/01/24 → 31/12/27
Projekt: Forschung
-
SOCoMED: Supramolecular Organometallic and Coordination Complexes for Medical Applications
Casini, A. (Leitende(r) Forscher/-in)
1/03/23 → 28/02/27
Projekt: Forschung
-
MiAMI: Machine Learning for Medicine: Accelerating Metadynamics of Supramolecular Host-Guest Complexes for Therapy and Imaging
Casini, A. (Leitende(r) Forscher/-in)
1/03/24 → 28/02/25
Projekt: Forschung
-
A Gold-PROTAC Degrades the Oncogenic Tyrosine Kinase MERTK: Insights into the Degradome from a Steady-State System
Thomas, S. R., Iellici, T., Park, M., Klaus, E., Bileck, A., Gerner, C., Meier-Menches, S. M. & Casini, A., 16 Jan. 2026, in: ACS Chemical Biology. 21, 1, S. 170-186 17 S.Publikation: Beitrag in Fachzeitschrift › Artikel › Begutachtung
Open Access -
A photocleavable peptidic Ru(ii) mass-tag enabling targeted DESI and MALDI mass spectrometry imaging in cancer tissues
Park, M., Gonçalves, J. P. L., Deiser, S., Fenzl, S., Böhm, F. A., Steiger, K., Kossatz, S., Strittmatter, N. & Casini, A., 2026, (Angenommen/Im Druck) in: Chemical Science.Publikation: Beitrag in Fachzeitschrift › Artikel › Begutachtung
Open Access -
A sstR2-targeted radiohybrid theranostic agent for PET imaging and β- therapy with excellent preclinical performance
Deiser, S., Fenzl, S., König, V., Inoue, S. & Casini, A., Dez. 2026, in: NPJ Imaging. 4, 1, 24.Publikation: Beitrag in Fachzeitschrift › Artikel › Begutachtung
Open Access -
Corrigendum to “The molecular mechanisms of antimetastatic ruthenium compounds explored through DIGE proteomics” J Inorg Biochem 2013 Jan:118:94–9. doi:10.1016/j.jinorgbio.2012.10.003. Epub 2012 Oct 14
Guidi, F., Modesti, A., Landini, I., Nobili, S., Mini, E., Bini, L., Puglia, M., Casini, A., Dyson, P. J., Gabbiani, C. & Messori, L., Juli 2026, in: Journal of Inorganic Biochemistry. 280, 113308.Publikation: Beitrag in Fachzeitschrift › Kommentar/Debatte
-
Polypyridyl Ru(II) tamoxifen analogues: Estrogen receptor-targeted dual photodynamic and chemotherapeutic agents
Moreno-Alcántar, G., Schmidt, C., Wragg, D. D., Scotti, R., Aguirre, I. I., Bonsignore, R., Casini, A. & Lovison, D., Apr. 2026, in: Journal of Inorganic Biochemistry. 277, 113202.Publikation: Beitrag in Fachzeitschrift › Artikel › Begutachtung
Open Access1 Zitat (Scopus)